Target Name: LOC105369302
NCBI ID: G105369302
Review Report on LOC105369302 Target / Biomarker Content of Review Report on LOC105369302 Target / Biomarker
LOC105369302
Other Name(s): Uncharacterized LOC105369302, transcript variant X1 | uncharacterized LOC105369302 | LOC105369302 variant X1

LOC105369302: A Drug Target / Disease Biomarker

LOC105369302 is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. LOC105369302 is characterized by a unique genetic sequence that gives it a distinct structure and function.

The protein encoded by LOC105369302 is made up of 254 amino acids. It has a molecular weight of 31.9 kDa and a pre-fractory pH of 9.9. LOC105369302 is found in a variety of cellular organelles, including the endoplasmic reticulum, mitochondria, and endosomes. It is also found in the cytoplasm of cells.

The function of LOC105369302 is not well understood, but it is thought to be involved in the regulation of cellular processes. It is suggested that LOC105369302 may be a drug target or biomarker, due to its unique structure and function.

One potential mechanism by which LOC105369302 may be involved in drug targeting is through its role in the regulation of cellular signaling pathways. LOC105369302 is known to be involved in the regulation of several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These pathways are involved in a variety of cellular processes, including cell growth, differentiation, and inflammation. Therefore, LOC105369302 may be a useful target for drugs that are designed to modulate these pathways.

Another potential mechanism by which LOC105369302 may be involved in drug targeting is through its role in the regulation of cellular apoptosis. LOC105369302 has been shown to be involved in the regulation of cell apoptosis, which is a natural process that is involved in the elimination of damaged or dysfunctional cells. Therefore, LOC105369302 may be a useful target for drugs that are designed to induce or inhibit apoptosis in cells.

In addition to its potential role in drug targeting, LOC105369302 is also thought to be a potential biomarker for a variety of diseases. For example, LOC105369302 has been shown to be decreased in the brains of individuals with Alzheimer's disease, a progressive neurodegenerative disorder. Therefore, LOC105369302 may be a useful biomarker for the diagnosis or treatment of Alzheimer's disease.

LOC105369302 is also thought to be involved in the regulation of cellular signaling pathways that are important for maintaining tissue homeostasis. For example, LOC105369302 has been shown to be involved in the regulation of the blood-brain barrier, which is responsible for maintaining the integrity of the barrier between the brain and the bloodstream. Therefore, LOC105369302 may be a useful target for drugs that are designed to modulate this barrier.

In conclusion, LOC105369302 is a protein that is expressed in various tissues of the body and is thought to be involved in the regulation of cellular processes. Its unique genetic sequence and its involvement in several cellular signaling pathways make it a potential drug target or biomarker. Further research is needed to fully understand the function of LOC105369302 and its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105369302

The "LOC105369302 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369302 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134 | LOC105370135 | LOC105370165